首页> 外文期刊>Journal of Clinical Immunology >Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.
【24h】

Circulating immune complexes and complement C4 null alleles in patients in patients operated on for premature atherosclerotic peripheral vascular disease.

机译:循环免疫复合物和补体C4核患者在患者对早动脉粥样硬化外周血血管疾病中进行的患者。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Circulating immune complexes can lead to vascular inflammation and premature atherosclerosis and the fourth component of complement, C4, plays an important role in the removal of immune complexes. The objective of this study was to analyze the relation between circulating immune complexes and C4 null alleles in patients operated on for peripheral vascular disease before the age of 50. The prevalence of circulating immune complexes and null alleles of C4 (C4Q0) was determined in 62 patients with peripheral atherosclerosis requiring surgery before 50 years of age and in a matched control group. C4A and C4B null alleles (C4A*Q0, C4B*Q0) were determined by electrophoresis of plasma, followed by immunofixation. C4A and C4B concentrations were measured by ELISA. Circulating immune complexes were determined by sucrose density gradient centrifugation and gel filtration. There was no difference in the distribution of C4Q0 between patients and controls. The patients had higher prevalences and levels of circulating immune complexes. This was correlated with the presence of C4Q0, especially C4A*Q0. There was an inverse correlation of concentration of circulating immune complexes with C4A levels and with ratio of C4A/B levels. Thus, a significant proportion of patients with premature peripheral atherosclerosis had circulating immune complexes and C4A*Q0 enhanced the propensity to immune complex formation. This might represent one mechanism for vascular damage in this patient group.
机译:循环免疫复合物可导致血管炎症和早产动脉粥样硬化,补体C4的第四组分在除去免疫复合物中起重要作用。本研究的目的是分析循环免疫复合物和在50岁之前对外周血血管疾病操作的患者中的循环免疫复合物和C4零等位基因之间的关系。在62中测定了循环免疫复合物和循环免疫复合物和零等位基因的患病率外周动脉粥样硬化的患者需要在50岁之前和匹配对照组之前进行手术。 C4A和C4B零等位基因(C4A * Q0,C4B * Q0)通过血浆电泳来确定,然后是免疫混件。通过ELISA测量C4A和C4B浓度。通过蔗糖密度梯度离心和凝胶过滤测定循环免疫复合物。患者与对照之间C4Q0的分布没有差异。患者具有更高的患病率和循环免疫复合物的水平。这与C4Q0的存在相关,特别是C4a * Q0。将循环免疫复合物的浓度与C4a水平和C4a / b水平的比例浓度呈逆相关性。因此,患有过早外周动脉粥样硬化的患者的大量比例的免疫复合物和C4a * Q0增强了免疫复合物形成的倾向。这可能代表该患者组中血管损伤的一种机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号